|
|||||
|
|
Dupilumab prevents flares in adults with moderate to severe atopic dermatitis in a 52-week randomized controlled phase 3 trial |
|
| Authors: | Joseph F. Merola Robert Sidbury Andreas Wollenberg Zhen Chen Annie Zhang Brad Shumel Ana B. Rossi |
| Affiliation: | 1. Brigham and Women''s Hospital, Harvard Medical School, Boston, Massachusetts;2. Seattle Children''s Hospital, Seattle, Washington;3. Ludwig-Maximilian University, Munich, Germany;4. Regeneron Pharmaceuticals, Inc., Tarrytown, New York;5. Sanofi Genzyme, Cambridge, Massachusetts |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |